RxDoctor Payments Data

Angelica Francu, MD

Family Medicine · Garden City, MINPI 1598745341

Payments from drug & device makers

$406in general payments, 2019–2025

Across 25 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$90
  • Pfizer$61
  • GSK$55
  • Exact Sciences$42
  • Novo Nordisk$29
  • Amarin Pharma, Inc.$29
  • plus $99 from 6 others

What the payments were for

  • Food & beverage$406100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$406 in reported general payments places this provider in the 55th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$45,234
Medicare patients
121
Services billed
445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter114$76,473
EliquisApixaban69$67,218
OzempicSemaglutide51$55,452
TrulicityDulaglutide52$55,348
RybelsusSemaglutide26$38,629
JardianceEmpagliflozin27$31,155
FarxigaDapagliflozin Propanediol27$28,861
Breo ElliptaFluticasone/Vilanterol14$6,261
Atorvastatin Calcium503$5,501
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate13$4,279
SymbicortBudesonide/Formoterol Fumarate11$3,914
Albuterol Sulfate HfaAlbuterol Sulfate121$3,712
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen122$2,584
Metformin Hcl278$2,287
Losartan Potassium226$2,286

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$29$94,08177 claims
GSKTrelegy Ellipta, Breo Ellipta$55$82,734128 claims
PfizerEliquis$61$67,21869 claims
AstraZenecaFarxiga, Symbicort$12$32,77438 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Garden City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →